Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL)

67 filings reported holding AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share as of Q3 2022.
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 49.2M shares of 265M outstanding shares and own 18.59% of the company stock.
Largest 10 shareholders include Blackstone Inc. (18M shares), Syncona Portfolio Ltd (7.35M shares), Nantahala Capital Management, LLC (5.22M shares), Frazier Life Sciences Management, L.P. (3.75M shares), TFG Asset Management GP Ltd (3.04M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), Pendal Group Ltd (1.37M shares), CITADEL ADVISORS LLC (1.14M shares), Alphabet Inc. (698K shares), and Capital World Investors (625K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.